121 related articles for article (PubMed ID: 21768487)
1. Rituximab for severe mucous membrane pemphigoid: safe enough to be drug of first choice?
Hertl M; Bernard P; Borradori L
Arch Dermatol; 2011 Jul; 147(7):855-6. PubMed ID: 21768487
[No Abstract] [Full Text] [Related]
2. Rituximab for patients with refractory mucous membrane pemphigoid.
Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
[TBL] [Abstract][Full Text] [Related]
3. Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab.
He Y; Shimoda M; Ono Y; Villalobos IB; Mitra A; Konia T; Grando SA; Zone JJ; Maverakis E
JAMA Dermatol; 2015 Jun; 151(6):646-50. PubMed ID: 25901938
[TBL] [Abstract][Full Text] [Related]
4. Treatment of mucous membrane pemphigoid with rituximab.
Heelan K; Walsh S; Shear NH
J Am Acad Dermatol; 2013 Aug; 69(2):310-1. PubMed ID: 23866864
[No Abstract] [Full Text] [Related]
5. Reply to "Treatment of mucous membrane pemphigoid with rituximab".
Ahmed AR; Shetty S
J Am Acad Dermatol; 2013 Aug; 69(2):311-2. PubMed ID: 23866865
[No Abstract] [Full Text] [Related]
6. Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.
Shetty S; Ahmed AR
J Am Acad Dermatol; 2013 Mar; 68(3):499-506. PubMed ID: 23200198
[TBL] [Abstract][Full Text] [Related]
7. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575
[No Abstract] [Full Text] [Related]
8. Refractory mucous membrane pemphigoid which developed after allogeneic stem cell transplantation and was successfully treated with rituximab.
Nishimura R; Fujimoto N; Kito K; Uchiyama K; Koga H; Hodohara K; Hashimoto T; Fujiyama Y; Tanaka T
Eur J Dermatol; 2013; 23(4):562-4. PubMed ID: 24001878
[No Abstract] [Full Text] [Related]
9. Taking responsibility for complex medical dermatology patient management.
Zone JJ
Arch Dermatol; 2011 Jul; 147(7):850. PubMed ID: 21768485
[No Abstract] [Full Text] [Related]
10. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
[TBL] [Abstract][Full Text] [Related]
11. Reframing risk part I: Legal and ethical standards for medical risk disclosure.
Stoff BK; Cruze D; Swerlick RA
J Am Acad Dermatol; 2013 Oct; 69(4):634-6. PubMed ID: 24034367
[No Abstract] [Full Text] [Related]
12. [Cicatricial pemphigoid, mucous membrane pemphigoid].
Doffoel-Hantz V; Robert PY; Bédane C
Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
[TBL] [Abstract][Full Text] [Related]
13. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
Li Y; Foshee JB; Sontheimer RD
J Am Acad Dermatol; 2011 Apr; 64(4):773-8. PubMed ID: 20494477
[TBL] [Abstract][Full Text] [Related]
14. Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.
Taverna JA; Lerner A; Bhawan J; Demierre MF
J Drugs Dermatol; 2007 Jul; 6(7):731-2. PubMed ID: 17763598
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome and safety of rituximab therapy for pemphigoid diseases.
Tovanabutra N; Payne AS
J Am Acad Dermatol; 2020 May; 82(5):1237-1239. PubMed ID: 31738960
[No Abstract] [Full Text] [Related]
16. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
[TBL] [Abstract][Full Text] [Related]
17. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
[No Abstract] [Full Text] [Related]
18. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab.
Huff SB; Vasu S; Kaffenberger BH
Int J Dermatol; 2019 Feb; 58(2):240-241. PubMed ID: 29707776
[No Abstract] [Full Text] [Related]
19. Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab.
Schumann T; Schmidt E; Booken N; Goerdt S; Goebeler M
Acta Derm Venereol; 2009; 89(1):101-2. PubMed ID: 19197558
[No Abstract] [Full Text] [Related]
20. Childhood ocular mucous membrane pemphigoid successfully treated with rituximab.
Flores-Climente V; Rozas-Muñoz E; Martínez-Grau A; Aucouturier F; Luna S; Baselga E
Pediatr Dermatol; 2019 Nov; 36(6):984-985. PubMed ID: 31448438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
